Immunoglobulin variants outside the Fc region

Details for Australian Patent Application No. 2005227326 (hide)

Owner Xencor, Inc

Inventors Karki, Sher Bahadur; Lazar, Gregory Alan

Agent Davies Collison Cave

Pub. Number AU-B-2005227326

PCT Pub. Number WO2005/092925

Priority 60/585,328 01.07.04 US; 60/614,944 29.09.04 US; 60/586,837 09.07.04 US; 60/556,353 24.03.04 US; 60/599,741 06.08.04 US; 60/619,409 14.10.04 US; 60/573,302 21.05.04 US; 60/607,398 02.09.04 US

Filing date 24 March 2005

Wipo publication date 6 October 2005

Acceptance publication date 3 December 2009

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/092925 Priority application(s): WO2005/092925

3 December 2009 Application Accepted

  Published as AU-B-2005227326

1 April 2010 Standard Patent Sealed

21 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005227328-Schweinfurthin analogues

2005227324-Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof